
News from Clinical Trials Arena
If you want to know if Clinical Trials Arena is credible or reliable, look no further. We rank Clinical Trials Arena as Unknown factuality. Find out more about our methodology here.
Information about Clinical Trials Arena
Where is Clinical Trials Arena located?Clinical Trials Arena's WebsiteMedia Bias Ratings
Do you diasgree?
Edit bias
Learn more about Media Bias Ratings.
Factuality
Learn more about Factuality Ratings
Reveal Factuality Ratings by upgrading to a Premium account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Ownership
Learn more about Ownership categories
Reveal Ownership Data by upgrading to a Vantage account.
Tap Upgrade to explore subscription options to meet all your reading needs.
Top Clinical Trials Arena News

United States · United StatesPasritamig, a first-in-class bispecific T-cell-engaging antibody, shows potential in mCRPC with outpatient dosing designed for the community settingSee the Story
Johnson & Johnson unveils first-in-human results for pasritamig, showing early anti-tumor activity in prostate cancer
79% Center coverage: 14 sources

CancerPfizer drug Braftovi achieved statistically significant and clinically meaningful improvement in overall survival for colorectal cancer patients in a Phase 3 clinical trial. The results will be presented Friday during the annual meeting of the American Society of Clinical Oncology. The post Precision Pfizer Drug Leads to ‘Unprecedented’ Survival in Colorectal Cancer, Data at ASCO Show appeared first on MedCity News.See the Story
Precision Pfizer Drug Leads to ‘Unprecedented’ Survival in Colorectal Cancer, Data at ASCO Show
60% Center coverage: 5 sources

Adjuvant Cemiplimab Improves Disease-Free Survival in High-Risk Cutaneous SCC
100% Center coverage: 1 sources
A Generative AI-Discovered TNIK Inhibitor for Idiopathic Pulmonary Fibrosis: a Randomized Phase 2a Trial
100% Center coverage: 1 sources
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO25: Focus V fails to show superiority over bevacizumab in first-line metastatic CRC
The Predictive Model for Risk of Chemotherapy-Induced Thrombocytopenia Based on Antineoplastic Drugs for Solid Tumors in Eastern China
100% Center coverage: 1 sources
ASCO25: Trodelvy and Keytruda to become new standard of care for frontline TNBC
ASCO 2025: AstraZeneca’s novel trial design for camizestrant pays off in breast cancer
100% Right coverage: 1 sources